Cerebral amyloidoma mimicking intracranial tumor: a case report
© Landau et al; licensee BioMed Central Ltd. 2010
Received: 3 February 2010
Accepted: 20 September 2010
Published: 20 September 2010
Cerebral amyloidoma is an infrequently recognized condition that can be confused with a more malignant etiology. Few cases have been reported. We present a case report and a review of the literature.
Our patient was a 64-year-old Caucasian man who was incidentally discovered to have a brain mass. He was found to have a cerebral amyloidoma.
After discovery of the true etiology of his brain abnormality, it was determined that our patient had a more benign disease than was initially feared. Cases such as this demonstrate why consideration of this disorder is important.
Cerebral amyloidomas are rare entities infrequently described in the medical literature. Most commonly, they are noticed incidentally on brain scans. Frequently, they are confused with primary brain neoplasms. The clinical course tends to be benign, although long-term data is lacking.
A staging evaluation was performed, including a CT scan of the chest, abdomen and pelvis, and an MRI scan of the spine to investigate for systemic findings of amyloidosis. The results of these tests were negative. To date, our patient remains well with no further episodes of seizure or neurological dysfunction. Follow-up MRI results have been negative to date. There are currently no plans for a repeat surgical procedure or repeat brain biopsies.
Amyloidosis is a heterogeneous group of diseases with complex pathogenesis and may take on many forms and manifest in various organ systems. The pathophysiology invariably results in extracellular deposition of insoluble proteins with β-pleated sheet as their secondary structure. It is the β-pleated sheet of amyloidogenic proteins that allows histochemical identification under light microscopy [1, 2].
Amyloid deposition within the brain parenchyma can take on many forms, of which isolated amyloidomas are the least common [3, 4]. More common forms of cerebral amyloidosis include senile plaques seen in ageing and Alzheimer disease (AD) and sporadic cerebral amyloid angiopathy (CAA), while hereditary cerebral amyloid angiopathy and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephatlopathy (CADASIL) are rare. The histopathology and distribution of cerebral amyloid found in our case are not consistent with any of these known entities [1, 4–7].
A review of the literature reveals fewer than 30 reported cases [4, 8]. Of these, the majority of presenting cases were initially thought to be primary intracerebral neoplasms. The average age of presentation is in the fourth decade, with a slight female predominance given the very finite number of cases available for review. As may be expected, clinical presentation is protean with seizure, headache, and cognitive decline reported. Cerebral white matter is the most commonly involved area, with lesions most often being supratentorial . Typically, non-contrast CTs show hyperdensities that will enhance with contrast. MRI is more difficult to interpret due to variable results on imaging with some historically appearing hypointense, some isointense, and others hyperintense on T1 and T2 images .
The clinical course is thought to be benign, with no cases that were resected recurring. However, lesions that were biopsied without resection have shown growth . Little is known about long-term effects on such patients as there are few published reports with data going beyond five years . There are also limited data on surgical follow-up. The literature shows that most lesions were resected due to concerns of primary brain tumor. However, there have been no observed malignant transformations or other pathology related to amyloidomas that have been incompletely resected, therefore surgery is not necessary for the majority of patients with amyloidoma confirmed by biopsy . There is no reported role for diffusion tensor imaging.
Although rarely encountered, primary cerebral amyloidomas need to remain in the differential diagnosis of patients presenting with a solitary cerebral mass. While little is known regarding the long-term outcomes, after resection the disease does not appear to progress. With increased recognition, more data may become available on overall prognosis, but at this time it appears to represent a favorable clinical course.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the journal's Editor-in-Chief.
- Spaar FW, Goebel HH, Volles E, Wickboldt J: Tumor like amyloid formation (amyloidoma) in the brain. J Neurol. 1981, 224: 171-182. 10.1007/BF00313279.View ArticlePubMedGoogle Scholar
- Gleener GG: Amyoid deposits and amyloidosis. The beta-fibrillosis. N Engl J Med. 1980, 302: 1283-1292. 10.1056/NEJM198006053022305.View ArticleGoogle Scholar
- Lee J, Krol G, Rosenblum M: Primary amyloidoma of the brain: CT and MR presentation. AJNR AM J Neuroradiol. 1995, 16: 712-714.PubMedGoogle Scholar
- Grandhi D, Wee R, Goyal M: CT and MRI imaging of intracerebral amylodioma: case report and review of the literature. AJNR Am J Neuroradiol. 2003, 24: 519-522.Google Scholar
- Taylor M, Doody G: CADASIL: a guide to a comparatively unrecognized condition in psychiatry. Adv Psychiatr Treat. 2008, 14: 350-357. 10.1192/apt.bp.107.004655.View ArticleGoogle Scholar
- Tian J, Shi J, Mann DM: Cerebral amyloid angiopathy and dementia. Panminerva Med. 2004, 46: 253-264.PubMedGoogle Scholar
- Razvi SS, Davidson R, Bone I, Muir KW: Is inadequate family history a barrier to diagnosis in CADASIL?. Acta Neurol Scand. 2005, 112: 323-326. 10.1111/j.1600-0404.2005.00495.x.View ArticlePubMedGoogle Scholar
- Fischer B, Palkovic S, Ricket C, Weckesser M, Wassmann H: Cerebral AL lambda-amyloidoma: clinical and pathomorphological characteristics. Review of the literature and of a patient. Amyloid. 2007, 14: 11-19. 10.1080/13506120600960585.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.